Assessment of Seven Contemporary IOL Power Calculation Methods in Two PARTIAL-Range of Field IOL Designs and a Novel Constant Optimization Technique - Top-Institutions - MDSpire

Assessment of Seven Contemporary IOL Power Calculation Methods in Two PARTIAL-Range of Field IOL Designs and a Novel Constant Optimization Technique

  • By

  • Meiyi Zhu

  • Zongsheng Zeng

  • Ziling Zhang

  • Guangbin Zhang

  • March 11, 2026

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Bascom Palmer Eye Institute
    Bascom Palmer Eye Institute

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Cataract Surgery
    • Refractive Surgery

  • #2

    Wills Eye Hospital
    Wills Eye Hospital

    Philadelphia, PA

    Key Differentiators

    • Ophthalmology
    • Cataract Surgery
    • Clinical Research

  • #3

    Moorfields Eye Hospital
    Moorfields Eye Hospital

    London, England

    Key Differentiators

    • Ophthalmology
    • Refractive Surgery
    • Clinical Trials

  • #4

    Johns Hopkins Wilmer Eye Institute
    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Cataract Surgery
    • Vision Science

  • #5

    Massachusetts Eye and Ear Infirmary
    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Refractive Surgery
    • Clinical Research

Original Source(s)

Assessment of Seven Contemporary IOL Power Calculation Methods in Two PARTIAL-Range of Field IOL Designs and a Novel Constant Optimization Technique

  • by Meiyi Zhu, Zongsheng Zeng, Ziling Zhang, Guangbin Zhang

  • March 11, 2026

Related Content

Letter From the Editor: IOLs in Refractive Cataract Surgery

In this issue of The Ophthalmic ASC, we interview several surgeons to discover what is in their IOL closets. It is fun to see what some of the top surgeons in the country use as their favorite IOLs and the different ASC inventory management solutions that can help make this possible!  

IL-6 Inhibitor Vamikibart Shows Efficacy Signals in DME Trial

At ARVO 2026, Arshad M. Khanani, MD, MA, FASRS, presented phase 2 data on vamikibart, an IL-6 inhibitor, in diabetic macular edema.

Image-Based Deep Learning for Cataract Diagnosis: Systematic Review and Meta-Analysis